Microfluidics Market - Global Forecast to 2029
商品番号 : SMB-7327
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年2月 |
| ページ数 | 365 |
| 図表数 | 396 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The Microfluidics market is projected to reach USD 32.67 Billion by 2029 from USD 22.43 Billion in 2024, growing at a CAGR of 7.8% during the forecast period.
マイクロ流体市場は、2024年の224億3,000万米ドルから2029年までに326億7,000万米ドルに達すると予測されており、予測期間中に7.8%のCAGRで成長します。
The market for microfluidics is expanding due to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like cancer and diabetes, which is propelling the application of microfluidics in healthcare. Furthermore, the use of microfluidic devices is increasing due to innovations in drug delivery , organ-on-a-chip technology, and personalized medicine. Additionally, the market is driven by the rise in proteomics and genomics associated research.
“Polymers to account for largest market share in 2023.”
The market for microfluidics is propelled by polymers because of their their low costs, ease of production and adaptability. Microfluidic device manufacturing often requires polymers such as polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA), and cyclic olefin copolymer (COC). These polymers are helpful in the fabrication of microfluidic channels and structures. Moreover, as compared to conventional materials like silicon or glass, polymers are easier to mold and also, enables cheaper manufacturing costs. The biocompatible property of polymers makes them useful for a variety of medical applications, including medication delivery, lab-on-a-chip, and diagnostics. Due to such advantages, polymers accounts for the largest share in the microfluidics market.
“Hospital and Diagnostic Centers to register highest growth rate in the market during the forecast period.”
Various significant factors are propelling the growth of hospitals and diagnostic centers in the microfluidics industry. One important factor is the rising requirement for point-of-care diagnostics, as they provides quick, on-site testing that improves patient outcomes. Microfluidics play a major role in this positive outcome as it offers faster and precise result . Moreover, the requirement for efficacious diagnostics in clinical settings has risen due to the increase in infectious diseases like COVID-19. These equipment decreases cost, expedites testing methods, and improve precision and accuracy of diagnosis.
“Asia Pacific to register highest growth rate in the market during the forecast period.”
The highest CAGR was registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific comprise India, China, Japan, Australia, South Korea and RoAPAC. The demand for innovative technologies is increasing, especially in China, India, and Japan. Microfluidic devices for diagnostic and therapeutic applications are used due to the rise in prevalence of chronic and infectious diseases and the increase in focus on early diagnosis and preventative healthcare. The region’s rising pharmaceutical and lifesciences industries are also undertaking research and development initiatives, which increases the requirement for microfluidics in personalized medicine and drug discovery.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
- By Designation: C-level– 14%, Director-level–10%, and Others–76%
- By Region: North America–40%, Europe-30%, Asia Pacific–22%, Rest of the World -8%.
Prominent players in this market are Abbott laboratories (US) , Agilent Technologies, Inc. (US), Aignep S.P.A (Italy), biomerieux (France), BD(US), Bio-Rad laboratories, Inc (US), Danaher Corporation (US), Illumina Inc. (US), Parker Hannifin Coporation (US), Thermo Fisher Scientific Inc. (US), SMC Corporation (Japan), Idex Corporation (US), Fortive Corporation (US), Perkinelmer, Inc. (US), F.Hoffmann-LA Roche Ltd (Switzerland), Standard Biotools Inc. (US), Quidelortho Corporation (US), Hologic Inc. (US), Dolomite Microfluidics (UK) and Elveflow (France).
Research Coverage
The report comprise segmentation that covers end users, products, applications, and geographic regions. It also covers the key drivers, restraints, opportunities, and challenges impacting the growth trajectory of the microfluidics market. The research offers stakeholders an in-depth analysis of market potential and challenges, with a focus on major players and competitive landscapes. Moreover, micromarkets are analysed as per their overall impact to the global microfluidics sector, growth patterns, and potential. The analysis forecasts rise in market segment revenues, focusing on five key regions.
Key Benefits of Buying the Report:
The purpose of this research is to assist both new and existing players in the microfluidics market to assess the sustainability of their investments by providing detailed and knowledgeable information. It offers a dataset to assist in making key decisions. This report’s potential to facilitate thorough risk evaluation and provide direction for investment decisions is one of its major benefit. Market segmentation according to end-users and geographical areas is provided in the study, that provides precise analysis and insights. It also provide significant trends, obstacles, opportunities, and drivers, giving stakeholders the information they require to make strategic decisions that help in their long-term growth.
The report provides the insights on the following pointers:
- Analysis of the key drivers, restraints, opportunities, and challenges affecting the microfluidics market growth: Innovative technology and increase in prevalence of chronic diseases ; increased cost of devices and stringent regulations ; increase in number of diagnostic centers.
- Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the microfluidics industry.
- Market Development: Details associated with profitable markets: this research studies the microfluidics business in various geographical regions.
- Market Diversification: In-depth understanding of innovative products, unexamined regions, recent developments, and expenditures in the microfluidics market.
- Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as Danaher Corporation (US), Illumina Inc. (US), biomerieux (France), Thermo Fisher Scientific Inc. (US) and Abbott laboratories (US).
Table of Contents
1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 INCLUSIONS & EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 33
1.4 MARKET STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.2 RESEARCH DESIGN 36
2.2.1 SECONDARY RESEARCH 37
2.2.1.1 Key data from secondary sources 38
2.2.2 PRIMARY RESEARCH 39
2.2.2.1 Key industry insights 40
2.3 MARKET SIZE ESTIMATION METHODOLOGY 41
2.3.1 BOTTOM-UP APPROACH 42
2.3.1.1 Approach 1: Company revenue estimation approach 43
2.3.1.2 Approach 2: Customer-based market estimation 44
2.3.1.3 Approach 3: Top-down approach 45
2.3.1.4 Approach 4: Primary interviews 45
2.3.1.5 Growth forecast 45
2.3.1.6 CAGR projection 46
2.3.2 TOP-DOWN APPROACH 46
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 47
2.5 MARKET SHARE ASSESSMENT 48
2.6 RESEARCH ASSUMPTIONS 48
2.7 RESEARCH LIMITATIONS 49
2.8 RISK ASSESSMENT 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 54
4.1 MICROFLUIDICS MARKET OVERVIEW 54
4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER AND COUNTRY (2023) 55
4.3 MICROFLUIDICS MARKET, BY REGION 56
4.4 GEOGRAPHIC SNAPSHOT OF MICROFLUIDICS MARKET 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing requirement for point-of-care testing 58
5.2.1.2 Rising technological advancements 58
5.2.1.3 Increasing focus on data precision and accuracy 59
5.2.1.4 Economic benefits associated with microfluidics 60
5.2.1.5 Portability with microfluidic chip miniaturization 60
5.2.1.6 Rising demand for effective sample analysis 61
5.2.2 RESTRAINTS 61
5.2.2.1 Stringent regulatory approval process 61
5.2.2.2 Integration of microfluidics into current workflow 62
5.2.3 OPPORTUNITIES 62
5.2.3.1 Emergence of 3D cell culture systems 62
5.2.3.2 Growth potential of emerging economies 63
5.2.3.3 Use of microfluidics in life sciences & pharmaceutical industries 64
5.2.4 CHALLENGES 65
5.2.4.1 Low adoption of microfluidic devices among end users 65
5.3 INDUSTRY TRENDS 65
5.3.1 E-HEALTH DIAGNOSTICS 65
5.3.2 INTEGRATION OF MICROFLUIDICS WITH 3D PRINTING 66
5.3.3 R&D INVESTMENTS FOR PRODUCT DEVELOPMENT 66
5.4 PORTER’S FIVE FORCES ANALYSIS 69
5.4.1 THREAT OF NEW ENTRANTS 70
5.4.2 THREAT OF SUBSTITUTES 70
5.4.3 BARGAINING POWER OF SUPPLIERS 70
5.4.4 BARGAINING POWER OF BUYERS 70
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 71
5.5 KEY STAKEHOLDERS & BUYING CRITERIA 71
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 71
5.5.2 BUYING CRITERIA 72
5.6 REGULATORY LANDSCAPE 72
5.6.1 NORTH AMERICA 72
5.6.1.1 US 72
5.6.1.2 Canada 74
5.6.2 EUROPE 75
5.6.3 ASIA PACIFIC 76
5.6.3.1 Japan 76
5.6.3.2 China 77
5.6.3.3 India 78
5.6.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
5.7 REIMBURSEMENT SCENARIO 81
5.8 ECOSYSTEM ANALYSIS 82
5.9 VALUE CHAIN ANALYSIS 84
5.9.1 RESEARCH & DEVELOPMENT 84
5.9.2 RAW MATERIAL PROCUREMENT & MANUFACTURING 85
5.9.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES 85
5.10 SUPPLY CHAIN ANALYSIS 86
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 87
5.12 IMPACT OF GEN AI ON MICROFLUIDICS MARKET 88
5.13 PATENT ANALYSIS 89
5.13.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS 89
5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 89
5.14 TRADE ANALYSIS 95
5.14.1 IMPORT DATA 95
5.14.2 EXPORT DATA (HS CODE 3822) 96
5.14.3 EXPORT DATA (HS CODE 8479) 96
5.15 TECHNOLOGY ANALYSIS 97
5.15.1 KEY TECHNOLOGIES 97
5.15.1.1 Biosensor elements 97
5.15.1.2 Materials science 98
5.15.1.3 Microfabrication 98
5.15.1.4 Direct-writing 99
5.15.1.5 Optofluidics 99
5.15.1.6 Acoustofluidics 99
5.15.2 COMPLEMENTARY TECHNOLOGIES 100
5.15.2.1 MEMS 100
5.15.2.1.1 Green microfluidics 100
5.15.2.1.2 Microsensors/transducers 100
5.15.3 ADJACENT TECHNOLOGIES 101
5.15.3.1 3D inkjet printing 101
5.15.3.2 Lab-on-fiber 101
5.16 KEY CONFERENCES & EVENTS 102
5.17 PRICING ANALYSIS 103
5.17.1 AVERAGE SELLING PRICE TREND, BY REGION 103
5.17.2 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER 105
5.18 UNMET NEEDS/END-USER EXPECTATIONS 106
5.19 CASE STUDY ANALYSIS 106
5.19.1 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ 106
5.19.2 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO 107
5.19.3 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY 108
5.20 INVESTMENT & FUNDING SCENARIO 109
6 MICROFLUIDICS MARKET, BY PRODUCT 111
6.1 INTRODUCTION 112
6.2 MICROFLUIDICS-BASED DEVICES 112
6.2.1 HIGH UPTAKE OF POC TESTING AND ORGAN-ON-A-CHIP SYSTEMS TO PROPEL MARKET 112
6.3 MICROFLUIDIC COMPONENTS 113
6.3.1 MICROFLUIDIC COMPONENTS, BY TYPE 114
6.3.1.1 Microfluidic chips 115
6.3.1.1.1 Chips to account for largest share of components market 115
6.3.1.2 Flow & pressure sensors 117
6.3.1.2.1 Utilization in lab diagnostics & research applications to drive market 117
6.3.1.3 Flow & pressure controllers 119
6.3.1.3.1 Cost-effectiveness and durability to boost demand 119
6.3.1.4 Microfluidic valves 120
6.3.1.4.1 Technological advancements to support market growth 120
6.3.1.5 Micropumps 124
6.3.1.5.1 Wide usage in drug delivery and glucose injections to fuel uptake 124
6.3.1.6 Microneedles 126
6.3.1.6.1 Miniscule size and painless patch application procedure to boost demand 126
6.3.1.7 Other microfluidic components 127
6.3.2 MICROFLUIDIC COMPONENTS, BY MATERIAL 128
6.3.2.1 Silicon 128
6.3.2.1.1 High precision and durability to boost demand 128
6.3.2.2 Polymers 129
6.3.2.2.1 Polymethyl methacrylate (PMMA) 130
6.3.2.2.1.1 Durable alternative to glass to fuel uptake 130
6.3.2.2.2 Polydimethylsiloxane (PDMS) 131
6.3.2.2.2.1 Limited compatibility with specific solvents and acids to limit market adoption 131
6.3.2.2.3 Cyclic olefin copolymers 131
6.3.2.2.3.1 Low water absorption and enhanced electrical insulation properties to boost demand 131
6.3.2.2.4 Other polymers 132
6.3.2.3 Glass 133
6.3.2.3.1 High cost and brittleness to restrain market 133
7 MICROFLUIDICS MARKET, BY APPLICATION 135
7.1 INTRODUCTION 136
7.2 IVD 136
7.2.1 CLINICAL DIAGNOSTICS 138
7.2.1.1 Growing focus on early disease detection to drive market 138
7.2.2 POINT-OF-CARE TESTING (POCT) 139
7.2.2.1 High uptake of lab-on-a-chip technologies to fuel uptake 139
7.2.3 VETERINARY DIAGNOSTICS 140
7.2.3.1 Detection of toxins in food through LOC systems to support market growth 140
7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH 141
7.3.1 LAB ANALYTICS 142
7.3.1.1 Proteomic analysis 143
7.3.1.1.1 Utilization of lab-on-a-chip devices for therapeutic development to drive market 143
7.3.1.2 Genomic analysis 144
7.3.1.2.1 Growing focus on NGS and digital PCR to boost demand 144
7.3.1.3 Cell-based assays 145
7.3.1.3.1 Drug screening for cross-reaction & toxicity testing to support market growth 145
7.3.1.4 Capillary electrophoresis 146
7.3.1.4.1 Growing applications for environmental monitoring and clinical diagnostics to fuel uptake 146
7.3.2 MICRODISPENSING 147
7.3.2.1 Suitability for low-viscosity applications to support market growth 147
7.3.3 MICROREACTORS 148
7.3.3.1 High uptake by leading companies for process optimization to fuel market 148
7.4 THERAPEUTICS 149
7.4.1 DRUG DELIVERY 150
7.4.1.1 Utilization of microneedles for painless and precise delivery to drive market 150
7.4.2 WEARABLE DEVICES 151
7.4.2.1 Integration of microfluidics-based wearable devices to support market growth 151
8 MICROFLUIDICS MARKET, BY END USER 153
8.1 INTRODUCTION 154
8.2 HOSPITALS AND DIAGNOSTIC CENTERS 154
8.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED EQUIPMENT AND FOCUS ON EARLY DISEASE DIAGNOSIS TO BOOST DEMAND 154
8.3 ACADEMIC & RESEARCH INSTITUTES 155
8.3.1 INVESTMENTS IN BIOMEDICAL & LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH 155
8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 158
8.4.1 GROWING FOCUS ON BIOMARKER & DRUG DISCOVERY TO PROPEL MARKET 158
9 MICROFLUIDICS MARKET, BY REGION 160
9.1 INTRODUCTION 161
9.2 NORTH AMERICA 161
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 162
9.2.2 US 168
9.2.2.1 High healthcare expenditure and wide adoption of technologically advanced products to drive market 168
9.2.3 CANADA 170
9.2.3.1 Government funds and focus on research to support market growth 170
9.3 EUROPE 172
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 172
9.3.2 GERMANY 177
9.3.2.1 Growing focus on proteomics & genomics research to drive market 177
9.3.3 FRANCE 179
9.3.3.1 Favorable government support for R&D to drive market 179
9.3.4 UK 182
9.3.4.1 Rising cases of chronic diseases and increasing demand for POC testing to boost demand 182
9.3.5 ITALY 184
9.3.5.1 Innovative development of microfluidic chips to boost demand 184
9.3.6 SPAIN 186
9.3.6.1 Growth in pharmaceutical industry to fuel uptake 186
9.3.7 REST OF EUROPE 188
9.4 ASIA PACIFIC 190
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 190
9.4.2 CHINA 197
9.4.2.1 Growing focus on nanotechnology to drive market 197
9.4.3 JAPAN 199
9.4.3.1 High investments in academic research activities to propel market 199
9.4.4 INDIA 201
9.4.4.1 Increasing prevalence of CVD and diabetes to support market growth 201
9.4.5 AUSTRALIA 204
9.4.5.1 Rising incidence of infectious diseases to fuel uptake 204
9.4.6 SOUTH KOREA 206
9.4.6.1 Increasing R&D expenditure to drive growth 206
9.4.7 REST OF ASIA PACIFIC 209
9.5 LATIN AMERICA 210
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 210
9.5.2 BRAZIL 215
9.5.2.1 Increasing development of disease diagnostics kits to fuel uptake 215
9.5.3 MEXICO 217
9.5.3.1 Rising prevalence of chronic diseases to boost demand for POC testing 217
9.5.4 REST OF LATIN AMERICA 219
9.6 MIDDLE EAST & AFRICA 221
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 222
9.6.2 GCC COUNTRIES 226
9.6.2.1 Adoption of advanced microfluidic devices to support market growth 226
9.6.3 REST OF MIDDLE EAST & AFRICA 228
10 COMPETITIVE LANDSCAPE 231
10.1 INTRODUCTION 231
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 231
10.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET 231
10.4 REVENUE ANALYSIS, 2019–2023 232
10.5 MARKET SHARE ANALYSIS, 2023 233
10.6 RANKING OF KEY MARKET PLAYERS 235
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 235
10.7.1 STARS 235
10.7.2 EMERGING LEADERS 235
10.7.3 PERVASIVE PLAYERS 236
10.7.4 PARTICIPANTS 236
10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 237
10.7.5.1 Company footprint 237
10.7.5.2 Product footprint 238
10.7.5.3 Application footprint 239
10.7.5.4 End-user footprint 240
10.7.5.5 Region footprint 241
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 242
10.8.1 PROGRESSIVE COMPANIES 242
10.8.2 RESPONSIVE COMPANIES 242
10.8.3 DYNAMIC COMPANIES 242
10.8.4 STARTING BLOCKS 242
10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 244
10.8.5.1 Detailed list of key startup/SME players 244
10.8.5.2 Competitive benchmarking of key emerging players/startups 245
10.9 COMPANY VALUATION & FINANCIAL METRICS 246
10.9.1 FINANCIAL METRICS 246
10.9.2 COMPANY VALUATION 246
10.10 BRAND/PRODUCT COMPARATIVE ANALYSIS 247
10.11 COMPETITIVE SCENARIO 248
10.11.1 PRODUCT LAUNCHES & APPROVALS 248
10.11.2 DEALS 249
10.11.3 EXPANSIONS 250
10.11.4 OTHER DEVELOPMENTS 250
11 COMPANY PROFILES 251
11.1 KEY PLAYERS 251
11.1.1 DANAHER CORPORATION 251
11.1.1.1 Business overview 251
11.1.1.2 Products offered 253
11.1.1.3 Recent developments 254
11.1.1.3.1 Deals 254
11.1.1.3.2 Expansions 255
11.1.1.4 MnM view 255
11.1.1.4.1 Key strengths 255
11.1.1.4.2 Strategic choices 255
11.1.1.4.3 Weaknesses & competitive threats 255
11.1.2 ILLUMINA, INC. 256
11.1.2.1 Business overview 256
11.1.2.2 Products offered 258
11.1.2.3 Recent developments 259
11.1.2.3.1 Product launches & approvals 259
11.1.2.3.2 Deals 259
11.1.2.4 MnM view 261
11.1.2.4.1 Key strengths 261
11.1.2.4.2 Strategic choices 261
11.1.2.4.3 Weaknesses & competitive threats 261
11.1.3 BIOMÉRIEUX 262
11.1.3.1 Business overview 262
11.1.3.2 Products offered 264
11.1.3.3 Recent developments 264
11.1.3.3.1 Product launches & approvals 264
11.1.3.3.2 Deals 265
11.1.3.4 MnM view 265
11.1.3.4.1 Key strengths 265
11.1.3.4.2 Strategic choices 265
11.1.3.4.3 Weaknesses & competitive threats 265
11.1.4 THERMO FISHER SCIENTIFIC INC. 266
11.1.4.1 Business overview 266
11.1.4.2 Products offered 268
11.1.4.3 Recent developments 269
11.1.4.3.1 Product launches & approvals 269
11.1.4.3.2 Deals 271
11.1.4.3.3 Expansions 272
11.1.4.4 MnM view 272
11.1.4.4.1 Key strengths 272
11.1.4.4.2 Strategic choices 272
11.1.4.4.3 Weaknesses & competitive threats 272
11.1.5 ABBOTT LABORATORIES 273
11.1.5.1 Business overview 273
11.1.5.2 Products offered 275
11.1.5.3 MnM view 276
11.1.5.3.1 Key strengths 276
11.1.5.3.2 Strategic choices 276
11.1.5.3.3 Weaknesses & competitive threats 276
11.1.6 PARKER HANNIFIN CORP 277
11.1.6.1 Business overview 277
11.1.6.2 Products offered 279
11.1.7 SMC CORPORATION 282
11.1.7.1 Business overview 282
11.1.7.2 Products offered 283
11.1.7.3 Recent developments 286
11.1.7.3.1 Product launches 286
11.1.8 IDEX CORPORATION 289
11.1.8.1 Business overview 289
11.1.8.2 Products offered 291
11.1.8.3 Recent developments 292
11.1.8.3.1 Deals 292
11.1.9 FORTIVE 293
11.1.9.1 Business overview 293
11.1.9.2 Products offered 295
11.1.10 REVVITY, INC. 297
11.1.10.1 Business overview 297
11.1.10.2 Products offered 298
11.1.10.3 Recent developments 300
11.1.10.3.1 Deals 300
11.1.11 AGILENT TECHNOLOGIES, INC. 301
11.1.11.1 Business overview 301
11.1.11.2 Products offered 303
11.1.11.3 Recent developments 304
11.1.11.3.1 Product launches 304
11.1.11.3.2 Deals 305
11.1.11.3.3 Expansions 305
11.1.12 BIO-RAD LABORATORIES, INC. 306
11.1.12.1 Business overview 306
11.1.12.2 Products offered 308
11.1.12.3 Recent developments 309
11.1.12.3.1 Product launches 309
11.1.12.3.2 Deals 310
11.1.13 BECTON, DICKINSON AND COMPANY 311
11.1.13.1 Business overview 311
11.1.13.2 Products offered 313
11.1.13.3 Recent developments 315
11.1.13.3.1 Product launches & approvals 315
11.1.13.3.2 Deals 316
11.1.13.3.3 Expansions 317
11.1.14 F. HOFFMANN-LA ROCHE LTD. 318
11.1.14.1 Business overview 318
11.1.14.2 Products offered 319
11.1.14.3 Recent developments 320
11.1.14.3.1 Product launches & approvals 320
11.1.14.3.2 Deals 321
11.1.15 STANDARD BIOTOOLS 322
11.1.15.1 Business overview 322
11.1.15.2 Products offered 324
11.1.15.3 Recent developments 325
11.1.15.3.1 Product launches & approvals 325
11.1.15.3.2 Deals 326
11.1.16 QUIDELORTHO CORPORATION 327
11.1.16.1 Business overview 327
11.1.16.2 Products offered 329
11.1.16.3 Recent developments 330
11.1.16.3.1 Product approvals 330
11.1.16.3.2 Deals 331
11.1.16.3.3 Expansions 331
11.1.17 HOLOGIC, INC. 332
11.1.17.1 Business overview 332
11.1.17.2 Products offered 334
11.1.17.3 Recent developments 334
11.1.17.3.1 Product approvals 334
11.1.17.3.2 Deals 334
11.1.18 AIGNEP S.P.A. 335
11.1.18.1 Business overview 335
11.1.18.2 Products offered 336
11.1.18.3 Recent developments 336
11.1.18.3.1 Deals 336
11.1.19 DOLOMITE MICROFLUIDICS 337
11.1.19.1 Business overview 337
11.1.19.2 Products offered 338
11.1.19.3 Recent developments 342
11.1.19.3.1 Product launches & approvals 342
11.1.19.3.2 Deals 342
11.1.19.3.3 Other developments 342
11.1.20 ELVEFLOW 343
11.1.20.1 Business overview 343
11.1.20.2 Products offered 343
11.2 OTHER PLAYERS 345
11.2.1 NANOSTRING TECHNOLOGIES 345
11.2.2 INNOVATIVE BIOCHIPS, LLC 346
11.2.3 FLUIDIC ANALYTICS 347
11.2.4 UFLUIDIX 348
11.2.5 HORIBA 349
11.2.6 MICRONIT B.V. 350
11.2.7 EMULATE INC. 351
11.2.8 SPHERE FLUIDICS LIMITED 352
11.2.9 ZEON CORPORATION 353
11.2.10 QIAGEN N.V. 354
12 APPENDIX 355
12.1 DISCUSSION GUIDE 355
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 361
12.3 CUSTOMIZATION OPTIONS 363
12.4 RELATED REPORTS 363
12.5 AUTHOR DETAILS 364
LIST OF TABLES
TABLE 1 MICROFLUIDICS MARKET: INCLUSIONS & EXCLUSIONS 32
TABLE 2 MICROFLUIDICS MARKET: STUDY ASSUMPTIONS 48
TABLE 3 RISK ASSESSMENT: MICROFLUIDICS MARKET 49
TABLE 4 PRODUCT LAUNCHES BY KEY PLAYERS, 2023 59
TABLE 5 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET 67
TABLE 6 MICROFLUIDICS MARKET: PORTER’S FIVE FORCES 69
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FOR MICROFLUIDICS MARKET 71
TABLE 8 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET, BY MATERIAL 72
TABLE 9 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED
DIAGNOSTIC DEVICES 73
TABLE 10 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 74
TABLE 11 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES 75
TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 77
TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 77
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 17 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 19 MAJOR CPT CODES FOR DIAGNOSTICS TESTS IN US, 2023 81
TABLE 20 MICROFLUIDICS MARKET: ROLE IN ECOSYSTEM 83
TABLE 21 APPLICATIONS OF ARTIFICIAL INTELLIGENCE-POWERED MICROFLUIDICS 88
TABLE 22 LIST OF MAJOR PATENT INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024 91
TABLE 23 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND) 95
TABLE 24 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019−2023 (USD THOUSAND) 96
TABLE 25 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2025-2026) 102
TABLE 26 AVERAGE SELLING PRICE OF MICROFLUIDICS MEDICINE EQUIPMENT,
BY REGION, 2022–2024 (USD THOUSAND) 104
TABLE 27 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2024 (USD) 105
TABLE 28 MICROFLUIDICS MARKET: CURRENT UNMET NEEDS 106
TABLE 29 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ 106
TABLE 30 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO 107
TABLE 31 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY 108
TABLE 32 MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 112
TABLE 33 MICROFLUIDICS-BASED DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 113
TABLE 34 MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 114
TABLE 35 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 114
TABLE 36 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS 115
TABLE 37 MICROFLUIDIC CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 38 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS 118
TABLE 39 FLOW & PRESSURE SENSORS MARKET, BY REGION, 2022–2029 (USD MILLION) 118
TABLE 40 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS 119
TABLE 41 FLOW & PRESSURE CONTROLLERS MARKET, BY REGION,
2022–2029 (USD MILLION) 120
TABLE 42 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS 121
TABLE 43 MICROFLUIDIC VALVES MARKET, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 44 MICROPUMPS OFFERED BY KEY PLAYERS 125
TABLE 45 MICROPUMPS MARKET, BY REGION, 2022–2029 (USD MILLION) 126
TABLE 46 MICRONEEDLES OFFERED BY KEY PLAYERS 127
TABLE 47 MICRONEEDLES MARKET, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 48 OTHER MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 127
TABLE 49 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 128
TABLE 50 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 129
TABLE 51 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 129
TABLE 52 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 130
TABLE 53 PMMA-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 130
TABLE 54 PDMS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 131
TABLE 55 COC-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 132
TABLE 56 OTHER POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 133
TABLE 57 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 134
TABLE 58 MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 136
TABLE 59 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE,
2022–2029 (USD MILLION) 137
TABLE 60 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY REGION,
2022–2029 (USD MILLION) 137
TABLE 61 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION,
2022–2029 (USD MILLION) 138
TABLE 62 MICROFLUIDICS MARKET FOR POCT, BY REGION, 2022–2029 (USD MILLION) 139
TABLE 63 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION,
2022–2029 (USD MILLION) 140
TABLE 64 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH,
BY TYPE, 2022–2029 (USD MILLION) 141
TABLE 65 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH,
BY REGION, 2022–2029 (USD MILLION) 142
TABLE 66 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2022–2029 (USD MILLION) 142
TABLE 67 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY REGION,
2022–2029 (USD MILLION) 143
TABLE 68 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY REGION,
2022–2029 (USD MILLION) 144
TABLE 69 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY REGION,
2022–2029 (USD MILLION) 145
TABLE 70 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY REGION,
2022–2029 (USD MILLION) 146
TABLE 71 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION,
2022–2029 (USD MILLION) 147
TABLE 72 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY REGION,
2022–2029 (USD MILLION) 148
TABLE 73 MICROFLUIDICS MARKET FOR MICROREACTORS, BY REGION,
2022–2029 (USD MILLION) 149
TABLE 74 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE,
2022–2029 (USD MILLION) 149
TABLE 75 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY REGION,
2022–2029 (USD MILLION) 150
TABLE 76 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY REGION,
2022–2029 (USD MILLION) 151
TABLE 77 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY REGION,
2022–2029 (USD MILLION) 152
TABLE 78 MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION) 154
TABLE 79 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION) 155
TABLE 80 LEADING MICROFLUIDICS RESEARCH INSTITUTES, BY AREA OF INTEREST 156
TABLE 81 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 157
TABLE 82 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 159
TABLE 83 MICROFLUIDICS MARKET, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 84 NORTH AMERICA: MACROECONOMIC OUTLOOK 162
TABLE 85 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 164
TABLE 86 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 164
TABLE 87 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 88 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 165
TABLE 89 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 90 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 91 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2022–2029 (USD MILLION) 166
TABLE 92 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE,
2022–2029 (USD MILLION) 166
TABLE 93 NORTH AMERICA: MICROFLUIDICS COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 166
TABLE 94 NORTH AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 95 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER,
2022–2029 (USD MILLION) 167
TABLE 96 US: KEY MACROINDICATORS 168
TABLE 97 US: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 168
TABLE 98 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 99 US: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 169
TABLE 100 US: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 169
TABLE 101 CANADA: KEY MACROINDICATORS 170
TABLE 102 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 171
TABLE 103 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 171
TABLE 104 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 171
TABLE 105 CANADA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 106 EUROPE: MACROECONOMIC OUTLOOK 173
TABLE 107 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 108 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 173
TABLE 109 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 174
TABLE 110 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 174
TABLE 111 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE,
2022–2029 (USD MILLION) 175
TABLE 112 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 113 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 114 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 115 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 176
TABLE 116 EUROPE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 117 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION) 177
TABLE 118 GERMANY: KEY MACROINDICATORS 178
TABLE 119 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 178
TABLE 120 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 178
TABLE 121 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 179
TABLE 122 GERMANY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 123 FRANCE: KEY MACROINDICATORS 180
TABLE 124 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 180
TABLE 125 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 181
TABLE 126 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 181
TABLE 127 FRANCE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 128 UK: KEY MACROINDICATORS 182
TABLE 129 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 183
TABLE 130 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 131 UK: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 183
TABLE 132 UK: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 184
TABLE 133 ITALY: KEY MACROINDICATORS 184
TABLE 134 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 185
TABLE 135 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 185
TABLE 136 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 185
TABLE 137 ITALY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 186
TABLE 138 SPAIN: KEY MACROINDICATORS 187
TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 187
TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 187
TABLE 141 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 188
TABLE 142 SPAIN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 188
TABLE 143 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 189
TABLE 144 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 189
TABLE 145 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 189
TABLE 146 REST OF EUROPE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 190
TABLE 147 ASIA PACIFIC: MACROECONOMIC INDICATORS 191
TABLE 148 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 149 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 193
TABLE 150 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 194
TABLE 151 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 194
TABLE 152 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE,
2022–2029 (USD MILLION) 195
TABLE 153 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 154 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 155 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 156 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 196
TABLE 157 ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER,
2022–2029 (USD MILLION) 197
TABLE 159 CHINA: KEY MACROINDICATORS 197
TABLE 160 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 198
TABLE 161 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 198
TABLE 162 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 198
TABLE 163 CHINA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 164 JAPAN: KEY MACROINDICATORS 200
TABLE 165 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 200
TABLE 166 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 200
TABLE 167 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 201
TABLE 168 JAPAN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 169 INDIA: KEY MACROINDICATORS 202
TABLE 170 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 202
TABLE 171 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 203
TABLE 172 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 203
TABLE 173 INDIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 204
TABLE 174 AUSTRALIA: KEY MACROINDICATORS 205
TABLE 175 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 205
TABLE 176 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 205
TABLE 177 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 206
TABLE 178 AUSTRALIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 179 SOUTH KOREA: KEY MACROINDICATORS 207
TABLE 180 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 207
TABLE 181 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 207
TABLE 182 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 208
TABLE 183 SOUTH KOREA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 184 REST OF ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 209
TABLE 185 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 209
TABLE 186 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 210
TABLE 187 REST OF ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 188 LATIN AMERICA: MACROECONOMIC OUTLOOK 211
TABLE 189 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 211
TABLE 190 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 211
TABLE 191 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 212
TABLE 192 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 212
TABLE 193 LATIN AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 194 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 195 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 196 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 197 LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 198 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 214
TABLE 199 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER,
2022–2029 (USD MILLION) 215
TABLE 200 BRAZIL: KEY MACROINDICATORS 215
TABLE 201 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 216
TABLE 202 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 216
TABLE 203 BRAZIL: MICROFLUIDICS COMPONENT MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 216
TABLE 204 BRAZIL: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 217
TABLE 205 MEXICO: KEY MACROINDICATORS 217
TABLE 206 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 218
TABLE 207 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 218
TABLE 208 MEXICO: MICROFLUIDICS MARKET, MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022–2029 (USD MILLION) 218
TABLE 209 MEXICO: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 210 REST OF LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 219
TABLE 211 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 220
TABLE 212 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 220
TABLE 213 REST OF LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 214 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY REGION,
2022–2029 (USD MILLION) 222
TABLE 215 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 222
TABLE 216 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 223
TABLE 217 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 218 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 224
TABLE 219 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 220 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL
& LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 221 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 222 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 223 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 225
TABLE 224 MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 225 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY END USER,
2022–2029 (USD MILLION) 226
TABLE 226 GCC COUNTRIES: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 227
TABLE 227 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 227
TABLE 228 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 228
TABLE 229 GCC COUNTRIES: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 230 REST OF MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 229
TABLE 231 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 232 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022–2029 (USD MILLION) 230
TABLE 233 REST OF MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 234 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 231
TABLE 235 MICROFLUIDICS MARKET: DEGREE OF COMPETITION 234
TABLE 236 MICROFLUIDICS MARKET: PRODUCT FOOTPRINT 238
TABLE 237 MICROFLUIDICS MARKET: APPLICATION FOOTPRINT 239
TABLE 238 MICROFLUIDICS MARKET: END-USER FOOTPRINT 240
TABLE 239 MICROFLUIDICS MARKET: REGION FOOTPRINT 241
TABLE 240 MICROFLUIDICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 244
TABLE 241 MICROFLUIDICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 245
TABLE 242 MICROFLUIDICS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−JANUARY 2025 248
TABLE 243 MICROFLUIDICS MARKET: DEALS, JANUARY 2021–JANUARY 2025 249
TABLE 244 MICROFLUIDICS MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 250
TABLE 245 MICROFLUIDICS MARKET: OTHER DEVELOPMENTS,
JANUARY 2021−JANUARY 2025 250
TABLE 246 DANAHER CORPORATION: COMPANY OVERVIEW 251
TABLE 247 DANAHER CORPORATION: PRODUCTS OFFERED 253
TABLE 248 DANAHER CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024 254
TABLE 249 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021−DECEMBER 2024 255
TABLE 250 ILLUMINA, INC.: COMPANY OVERVIEW 256
TABLE 251 ILLUMINA INC.: PRODUCTS OFFERED 258
TABLE 252 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−DECEMBER 2024 259
TABLE 253 ILLUMINA, INC.: DEALS, JANUARY 2021−DECEMBER 2024 259
TABLE 254 BIOMÉRIEUX: COMPANY OVERVIEW 262
TABLE 255 BIOMÉRIEUX: PRODUCTS OFFERED 264
TABLE 256 BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024 264
TABLE 257 BIOMÉRIEUX: DEALS, JANUARY 2021–AUGUST 2024 265
TABLE 258 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 266
TABLE 259 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 268
TABLE 260 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−DECEMBER 2024 269
TABLE 261 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2024 271
TABLE 262 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024 272
TABLE 263 ABBOTT LABORATORIES: COMPANY OVERVIEW 273
TABLE 264 ABBOTT LABORATORIES: PRODUCTS OFFERED 275
TABLE 265 PARKER HANNIFIN CORP: COMPANY OVERVIEW 277
TABLE 266 PARK HANNIFIN CORP: PRODUCTS OFFERED 279
TABLE 267 SMC CORPORATION: COMPANY OVERVIEW 282
TABLE 268 SMC CORPORATION: PRODUCTS OFFERED 283
TABLE 269 SMC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024 286
TABLE 270 IDEX CORPORATION: COMPANY OVERVIEW 289
TABLE 271 IDEX CORPORATION: PRODUCTS OFFERED 291
TABLE 272 IDEX CORPORATION: DEALS, JANUARY 2021–AUGUST 2024 292
TABLE 273 FORTIVE: COMPANY OVERVIEW 293
TABLE 274 FORTIVE: PRODUCTS OFFERED 295
TABLE 275 REVVITY INC.: COMPANY OVERVIEW 297
TABLE 276 REVVITY, INC.: PRODUCTS OFFERED 298
TABLE 277 REVVITY, INC.: DEALS, JANUARY 2021–JANUARY 2025 300
TABLE 278 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 301
TABLE 279 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 303
TABLE 280 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES,
JANUARY 2021–DECEMBER 2024 304
TABLE 281 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–AUGUST 2024 305
TABLE 282 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024 305
TABLE 283 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 306
TABLE 284 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 308
TABLE 285 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES,
JANUARY 2021–AUGUST 2024 309
TABLE 286 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2024 310
TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 311
TABLE 288 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 313
TABLE 289 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 315
TABLE 290 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2024 316
TABLE 291 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021–AUGUST 2024 317
TABLE 292 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 318
TABLE 293 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 319
TABLE 294 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024 320
TABLE 295 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2024 321
TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW 322
TABLE 297 STANDARD BIOTOOLS: PRODUCTS OFFERED 324
TABLE 298 STANDARD BIOTOOLS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024 325
TABLE 299 STANDARD BIOTOOLS: DEALS, JANUARY 2021–AUGUST 2024 326
TABLE 300 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 327
TABLE 301 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 329
TABLE 302 QUIDELORTHO CORPORATION: PRODUCT APPROVALS,
JANUARY 2021–DECEMBER 2024 330
TABLE 303 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–AUGUST 2024 331
TABLE 304 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024 331
TABLE 305 HOLOGIC, INC.: COMPANY OVERVIEW 332
TABLE 306 HOLOGIC, INC.: PRODUCTS OFFERED 334
TABLE 307 HOLOGIC, INC.: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024 334
TABLE 308 HOLOGIC, INC.: DEALS, JANUARY 2021–AUGUST 2024 334
TABLE 309 AIGNEP S.P.A.: COMPANY OVERVIEW 335
TABLE 310 AIGNEP S.P.A.: PRODUCTS OFFERED 336
TABLE 311 AIGNEP S.P.A.: DEALS, JANUARY 2021–AUGUST 2024 336
TABLE 312 DOLOMITE MICROFLUIDICS: COMPANY OVERVIEW 337
TABLE 313 DOLOMITE MICROFLUIDICS: PRODUCTS OFFERED 338
TABLE 314 DOLOMITE MICROFLUIDICS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024 342
TABLE 315 DOLOMITE MICROFLUIDICS: DEALS, JANUARY 2021–AUGUST 2024 342
TABLE 316 DOLOMITE MICROFLUIDICS: OTHER DEVELOPMENTS,
JANUARY 2021−DECEMBER 2024 342
TABLE 317 ELVEFLOW: COMPANY OVERVIEW 343
TABLE 318 ELVEFLOW: PRODUCTS OFFERED 343
TABLE 319 NANOSTRING TECHNOLOGIES: COMPANY OVERVIEW 345
TABLE 320 INNOVATIVE BIOCHIPS, LLC: COMPANY OVERVIEW 346
TABLE 321 FLUIDIC ANALYTICS: COMPANY OVERVIEW 347
TABLE 322 UFLUIDIX: COMPANY OVERVIEW 348
TABLE 323 HORIBA: COMPANY OVERVIEW 349
TABLE 324 MICRONIT B.V.: COMPANY OVERVIEW 350
TABLE 325 EMULATE INC.: COMPANY OVERVIEW 351
TABLE 326 SPHERE FLUIDICS LIMITED: COMPANY OVERVIEW 352
TABLE 327 ZEON CORPORATION: COMPANY OVERVIEW 353
TABLE 328 QIAGEN N.V.: COMPANY OVERVIEW 354
LIST OF FIGURES
FIGURE 1 MICROFLUIDICS MARKET SEGMENTATION 31
FIGURE 2 MICROFLUIDICS MARKET: RESEARCH DESIGN 36
FIGURE 3 PRIMARY SOURCES 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 41
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 42
FIGURE 7 MICROFLUIDICS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 43
FIGURE 8 MICROFLUIDICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 44
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46
FIGURE 10 TOP-DOWN APPROACH 46
FIGURE 11 DATA TRIANGULATION 47
FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 50
FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 51
FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 52
FIGURE 15 MICROFLUIDICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 52
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MICROFLUIDICS MARKET, 2024–2029 53
FIGURE 17 GROWING DEMAND FOR POINT-OF-CARE TESTING TO DRIVE MARKET 54
FIGURE 18 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE FOR JAPAN IN 2023 55
FIGURE 19 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET IN 2024 56
FIGURE 20 CHINA TO ACCOUNT FOR HIGHEST GROWTH RATE DURING FORECAST PERIOD 56
FIGURE 21 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
FIGURE 22 MICROFLUIDICS MARKET: PORTER’S FIVE FORCES ANALYSIS 69
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET, BY MATERIAL 71
FIGURE 24 KEY BUYING CRITERIA, BY MATERIAL 72
FIGURE 25 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY 73
FIGURE 26 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED
IVD DEVICES IN CANADA 74
FIGURE 27 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 76
FIGURE 28 INDIA: REGULATORY PROCESS FOR IVD DEVICES 78
FIGURE 29 MICROFLUIDICS MARKET: ECOSYSTEM ANALYSIS 82
FIGURE 30 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS 85
FIGURE 31 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS 87
FIGURE 32 REVENUE SHIFT AND NEW REVENUE POCKETS 87
FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2014–DECEMBER 2024) 90
FIGURE 34 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND) 95
FIGURE 35 EXPORT DATA FOR HS CODE 8479, BY COUNTRY, 2019−2023 (USD THOUSAND) 96
FIGURE 36 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022–2024 (USD) 104
FIGURE 37 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER 105
FIGURE 38 INVESTMENT & FUNDING SCENARIO, 2019−2023 109
FIGURE 39 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 109
FIGURE 40 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 110
FIGURE 41 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT 163
FIGURE 42 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT 192
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2019−2023) 233
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2023) 233
FIGURE 45 RANKING OF KEY PLAYERS IN MICROFLUIDICS MARKET, 2023 235
FIGURE 46 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 236
FIGURE 47 MICROFLUIDICS MARKET: COMPANY FOOTPRINT 237
FIGURE 48 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 243
FIGURE 49 EV/EBITDA OF KEY VENDORS 246
FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 246
FIGURE 51 MICROFLUIDICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 247
FIGURE 52 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 252
FIGURE 53 ILLUMINA, INC.: COMPANY SNAPSHOT (2023) 257
FIGURE 54 BIOMÉRIEUX: COMPANY SNAPSHOT (2023) 263
FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 267
FIGURE 56 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 274
FIGURE 57 PARKER HANNIFIN CORP: COMPANY SNAPSHOT (2023) 278
FIGURE 58 SMC CORPORATION: COMPANY SNAPSHOT (2023) 282
FIGURE 59 IDEX CORPORATION: COMPANY SNAPSHOT (2023) 290
FIGURE 60 FORTIVE: COMPANY SNAPSHOT (2023) 294
FIGURE 61 REVVITY, INC.: COMPANY SNAPSHOT (2021) 298
FIGURE 62 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 302
FIGURE 63 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 307
FIGURE 64 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 312
FIGURE 65 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 319
FIGURE 66 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023) 323
FIGURE 67 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023) 328
FIGURE 68 HOLOGIC, INC.: COMPANY SNAPSHOT (2023) 333
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。
最新調査レポート
- 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
- スマートメーター市場 – 2030年までの世界予測 2025-03-07
- 産業用計測市場 – 2030年までの世界予測 2025-03-06
- 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
- グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06